Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia.

GlobeNewswire April 16, 2019

IIROC Trading Resumption - ADK

Canada NewsWire April 10, 2019

DIAGNOS Announces Approval of Corporate Reorganization

GlobeNewswire April 10, 2019

IIROC Trading Halt - ADK

Canada NewsWire April 10, 2019

DIAGNOS Announces New Contract with Government in Bangladesh Through its Partner Eyes for All

GlobeNewswire April 2, 2019

IIROC Trading Resumption - ADK

Canada NewsWire March 27, 2019

DIAGNOS Announces an Update to the News Release Issued Earlier Today

GlobeNewswire March 27, 2019

IIROC Trading Halt - ADK

Canada NewsWire March 27, 2019

DIAGNOS Announces Memorandum of Understanding with one of the 5 largest hospitals in the US for the final development of its CARDIO application

GlobeNewswire March 27, 2019

DIAGNOS Announces New Agreement in the United Arab Emirates with one of the Largest Pharmaceutical Companies in the World

GlobeNewswire March 13, 2019

DIAGNOS Announces Corporate Reorganization

GlobeNewswire March 11, 2019

DIAGNOS Welcomes Dr. Jean-Francois Yale to the Board of Directors

GlobeNewswire January 29, 2019

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

GlobeNewswire January 22, 2019

DIAGNOS Announces Closing of Private Placement

GlobeNewswire December 12, 2018

DIAGNOS is announcing a collaboration with ÉTS on Automated detection and grading of Diabetic Retinopathy using Deep Convolutional Neural Networks, (CNN) a new generation of Deep Learning Technique  

GlobeNewswire December 4, 2018

DIAGNOS Announces Final Closing of Private Placement

GlobeNewswire November 21, 2018

DIAGNOS Enters into a Shares for Debt Transaction

GlobeNewswire November 21, 2018

DIAGNOS Announces Today the Addition of a Strategic Partner in the Country of Mexico

GlobeNewswire November 13, 2018

DIAGNOS Announces Closing of Private Placement

GlobeNewswire November 9, 2018

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants

GlobeNewswire November 6, 2018